Loading…

Repair of Coronary Arterioles After Treatment With Perindopril in Hypertensive Heart Disease

In hypertensive heart disease, no data are available on the repair of coronary resistance vessels in patients after long-term ACE inhibitor treatment. Fourteen patients with essential hypertension were studied with coronary flow reserve and with transvenous endomyocardial biopsy before and after 12...

Full description

Saved in:
Bibliographic Details
Published in:Hypertension (Dallas, Tex. 1979) Tex. 1979), 2000-08, Vol.36 (2), p.220-225
Main Authors: Schwartzkopff, Bodo, Brehm, Michael, Mundhenke, Markus, Strauer, Bodo E
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c4762-79d74a9b8735d0ffaab78562b7ea2ba2960c144957861a59417514df15f73a1a3
cites cdi_FETCH-LOGICAL-c4762-79d74a9b8735d0ffaab78562b7ea2ba2960c144957861a59417514df15f73a1a3
container_end_page 225
container_issue 2
container_start_page 220
container_title Hypertension (Dallas, Tex. 1979)
container_volume 36
creator Schwartzkopff, Bodo
Brehm, Michael
Mundhenke, Markus
Strauer, Bodo E
description In hypertensive heart disease, no data are available on the repair of coronary resistance vessels in patients after long-term ACE inhibitor treatment. Fourteen patients with essential hypertension were studied with coronary flow reserve and with transvenous endomyocardial biopsy before and after 12 months of antihypertensive treatment with perindopril (4 to 8 mg/d, mean 5.9±2.3 mg/d). Left ventricular muscle mass index decreased by 11% (from 145±41 to 128±36 g/m, P =0.04). Maximal coronary blood flow was increased by 54% (from 170±46 to 263±142 mL · min · 100 g, P =0.001), and minimal coronary vascular resistance was diminished by 33% (from 0.67±0.21 to 0.45±0.19 mm Hg · min · 100 g · mL, P =0.001); consequently, coronary reserve increased by 67% from 2.1±0.6 to 3.5±1.9 (P =0.001). Structural analysis revealed regression of periarteriolar collagen area by 54% (from 558±270 to 260±173 μm, P =0.04) and of total interstitial collagen volume density by 22% (from 5.5±3.8 Vv% to 4.3±3.2 Vv%, P =0.04), whereas arteriolar wall area was slightly but not significantly reduced. Long-term therapy with the ACE inhibitor perindopril induces structural repair of coronary arterioles that is mainly characterized by the regression of periarteriolar fibrosis and associated with a marked improvement in coronary reserve. These findings indicate the beneficial reparative effects of ACE inhibition on coronary microcirculation in hypertensive heart disease.
doi_str_mv 10.1161/01.HYP.36.2.220
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_71761000</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>58594090</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4762-79d74a9b8735d0ffaab78562b7ea2ba2960c144957861a59417514df15f73a1a3</originalsourceid><addsrcrecordid>eNpdkVFr2zAQgMVYWdNsz3sbYoy-2dXJsiQ_hqxdBoWV0bENBuJsn4k7x0ole6X_fioJbPTh0MF9d9x9YuwtiBxAw4WAfPPzJi90LnMpxQu2gFKqTJW6eMkWAiqVVQA_TtlZjHdCgFLKvGKnICplhYUF-_WV9tgH7ju-9sGPGB75KkwUej9Q5Ksupfw2EE47Gif-vZ-2_CZVx9bvQz_wfuSbxz2ljjH2f4hvCMPEP_aRMNJrdtLhEOnN8V2yb1eXt-tNdv3l0-f16jprlNEyM1VrFFa1NUXZiq5DrI0ttawNoaxRVlo0afOqNFYDlpUCU4JqOyg7UyBgsWTnh7n74O9nipPb9bGhYcCR_BydAaNBCJHA98_AOz-HMe3mpCilBWNVgi4OUBN8jIE6ly7dJTEOhHuy7gS4ZN0V2kmXrKeOd8exc72j9j_-oDkBH44AxgaHLuDY9PEfp4wt0pctmTpgD35I3uPvYX6g4LaEw7R16QChpLaZfMpsiiwFyOIvSMeYdA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>205281784</pqid></control><display><type>article</type><title>Repair of Coronary Arterioles After Treatment With Perindopril in Hypertensive Heart Disease</title><source>EZB Electronic Journals Library</source><creator>Schwartzkopff, Bodo ; Brehm, Michael ; Mundhenke, Markus ; Strauer, Bodo E</creator><creatorcontrib>Schwartzkopff, Bodo ; Brehm, Michael ; Mundhenke, Markus ; Strauer, Bodo E</creatorcontrib><description>In hypertensive heart disease, no data are available on the repair of coronary resistance vessels in patients after long-term ACE inhibitor treatment. Fourteen patients with essential hypertension were studied with coronary flow reserve and with transvenous endomyocardial biopsy before and after 12 months of antihypertensive treatment with perindopril (4 to 8 mg/d, mean 5.9±2.3 mg/d). Left ventricular muscle mass index decreased by 11% (from 145±41 to 128±36 g/m, P =0.04). Maximal coronary blood flow was increased by 54% (from 170±46 to 263±142 mL · min · 100 g, P =0.001), and minimal coronary vascular resistance was diminished by 33% (from 0.67±0.21 to 0.45±0.19 mm Hg · min · 100 g · mL, P =0.001); consequently, coronary reserve increased by 67% from 2.1±0.6 to 3.5±1.9 (P =0.001). Structural analysis revealed regression of periarteriolar collagen area by 54% (from 558±270 to 260±173 μm, P =0.04) and of total interstitial collagen volume density by 22% (from 5.5±3.8 Vv% to 4.3±3.2 Vv%, P =0.04), whereas arteriolar wall area was slightly but not significantly reduced. Long-term therapy with the ACE inhibitor perindopril induces structural repair of coronary arterioles that is mainly characterized by the regression of periarteriolar fibrosis and associated with a marked improvement in coronary reserve. These findings indicate the beneficial reparative effects of ACE inhibition on coronary microcirculation in hypertensive heart disease.</description><identifier>ISSN: 0194-911X</identifier><identifier>EISSN: 1524-4563</identifier><identifier>DOI: 10.1161/01.HYP.36.2.220</identifier><identifier>PMID: 10948081</identifier><identifier>CODEN: HPRTDN</identifier><language>eng</language><publisher>Philadelphia, PA: American Heart Association, Inc</publisher><subject>Angiotensin-Converting Enzyme Inhibitors - therapeutic use ; Antihypertensive agents ; Arterioles - drug effects ; Arterioles - pathology ; Arterioles - physiopathology ; Biological and medical sciences ; Blood Pressure - drug effects ; Cardiovascular system ; Coronary Circulation - drug effects ; Coronary Vessels - drug effects ; Coronary Vessels - pathology ; Coronary Vessels - physiopathology ; Dipyridamole - pharmacology ; Female ; Heart Diseases - drug therapy ; Heart Diseases - physiopathology ; Heart Ventricles - drug effects ; Heart Ventricles - pathology ; Hemodynamics - drug effects ; Humans ; Hypertension - drug therapy ; Hypertension - physiopathology ; Male ; Medical sciences ; Middle Aged ; Myocardium - pathology ; Perindopril - therapeutic use ; Pharmacology. Drug treatments ; Prospective Studies ; Treatment Outcome ; Vascular Resistance - drug effects ; Vasodilator Agents - pharmacology</subject><ispartof>Hypertension (Dallas, Tex. 1979), 2000-08, Vol.36 (2), p.220-225</ispartof><rights>2000 American Heart Association, Inc.</rights><rights>2000 INIST-CNRS</rights><rights>Copyright American Heart Association, Inc. Aug 2000</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4762-79d74a9b8735d0ffaab78562b7ea2ba2960c144957861a59417514df15f73a1a3</citedby><cites>FETCH-LOGICAL-c4762-79d74a9b8735d0ffaab78562b7ea2ba2960c144957861a59417514df15f73a1a3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=1478356$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/10948081$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Schwartzkopff, Bodo</creatorcontrib><creatorcontrib>Brehm, Michael</creatorcontrib><creatorcontrib>Mundhenke, Markus</creatorcontrib><creatorcontrib>Strauer, Bodo E</creatorcontrib><title>Repair of Coronary Arterioles After Treatment With Perindopril in Hypertensive Heart Disease</title><title>Hypertension (Dallas, Tex. 1979)</title><addtitle>Hypertension</addtitle><description>In hypertensive heart disease, no data are available on the repair of coronary resistance vessels in patients after long-term ACE inhibitor treatment. Fourteen patients with essential hypertension were studied with coronary flow reserve and with transvenous endomyocardial biopsy before and after 12 months of antihypertensive treatment with perindopril (4 to 8 mg/d, mean 5.9±2.3 mg/d). Left ventricular muscle mass index decreased by 11% (from 145±41 to 128±36 g/m, P =0.04). Maximal coronary blood flow was increased by 54% (from 170±46 to 263±142 mL · min · 100 g, P =0.001), and minimal coronary vascular resistance was diminished by 33% (from 0.67±0.21 to 0.45±0.19 mm Hg · min · 100 g · mL, P =0.001); consequently, coronary reserve increased by 67% from 2.1±0.6 to 3.5±1.9 (P =0.001). Structural analysis revealed regression of periarteriolar collagen area by 54% (from 558±270 to 260±173 μm, P =0.04) and of total interstitial collagen volume density by 22% (from 5.5±3.8 Vv% to 4.3±3.2 Vv%, P =0.04), whereas arteriolar wall area was slightly but not significantly reduced. Long-term therapy with the ACE inhibitor perindopril induces structural repair of coronary arterioles that is mainly characterized by the regression of periarteriolar fibrosis and associated with a marked improvement in coronary reserve. These findings indicate the beneficial reparative effects of ACE inhibition on coronary microcirculation in hypertensive heart disease.</description><subject>Angiotensin-Converting Enzyme Inhibitors - therapeutic use</subject><subject>Antihypertensive agents</subject><subject>Arterioles - drug effects</subject><subject>Arterioles - pathology</subject><subject>Arterioles - physiopathology</subject><subject>Biological and medical sciences</subject><subject>Blood Pressure - drug effects</subject><subject>Cardiovascular system</subject><subject>Coronary Circulation - drug effects</subject><subject>Coronary Vessels - drug effects</subject><subject>Coronary Vessels - pathology</subject><subject>Coronary Vessels - physiopathology</subject><subject>Dipyridamole - pharmacology</subject><subject>Female</subject><subject>Heart Diseases - drug therapy</subject><subject>Heart Diseases - physiopathology</subject><subject>Heart Ventricles - drug effects</subject><subject>Heart Ventricles - pathology</subject><subject>Hemodynamics - drug effects</subject><subject>Humans</subject><subject>Hypertension - drug therapy</subject><subject>Hypertension - physiopathology</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Myocardium - pathology</subject><subject>Perindopril - therapeutic use</subject><subject>Pharmacology. Drug treatments</subject><subject>Prospective Studies</subject><subject>Treatment Outcome</subject><subject>Vascular Resistance - drug effects</subject><subject>Vasodilator Agents - pharmacology</subject><issn>0194-911X</issn><issn>1524-4563</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2000</creationdate><recordtype>article</recordtype><recordid>eNpdkVFr2zAQgMVYWdNsz3sbYoy-2dXJsiQ_hqxdBoWV0bENBuJsn4k7x0ole6X_fioJbPTh0MF9d9x9YuwtiBxAw4WAfPPzJi90LnMpxQu2gFKqTJW6eMkWAiqVVQA_TtlZjHdCgFLKvGKnICplhYUF-_WV9tgH7ju-9sGPGB75KkwUej9Q5Ksupfw2EE47Gif-vZ-2_CZVx9bvQz_wfuSbxz2ljjH2f4hvCMPEP_aRMNJrdtLhEOnN8V2yb1eXt-tNdv3l0-f16jprlNEyM1VrFFa1NUXZiq5DrI0ttawNoaxRVlo0afOqNFYDlpUCU4JqOyg7UyBgsWTnh7n74O9nipPb9bGhYcCR_BydAaNBCJHA98_AOz-HMe3mpCilBWNVgi4OUBN8jIE6ly7dJTEOhHuy7gS4ZN0V2kmXrKeOd8exc72j9j_-oDkBH44AxgaHLuDY9PEfp4wt0pctmTpgD35I3uPvYX6g4LaEw7R16QChpLaZfMpsiiwFyOIvSMeYdA</recordid><startdate>200008</startdate><enddate>200008</enddate><creator>Schwartzkopff, Bodo</creator><creator>Brehm, Michael</creator><creator>Mundhenke, Markus</creator><creator>Strauer, Bodo E</creator><general>American Heart Association, Inc</general><general>Lippincott</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>K9.</scope><scope>7X8</scope></search><sort><creationdate>200008</creationdate><title>Repair of Coronary Arterioles After Treatment With Perindopril in Hypertensive Heart Disease</title><author>Schwartzkopff, Bodo ; Brehm, Michael ; Mundhenke, Markus ; Strauer, Bodo E</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4762-79d74a9b8735d0ffaab78562b7ea2ba2960c144957861a59417514df15f73a1a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2000</creationdate><topic>Angiotensin-Converting Enzyme Inhibitors - therapeutic use</topic><topic>Antihypertensive agents</topic><topic>Arterioles - drug effects</topic><topic>Arterioles - pathology</topic><topic>Arterioles - physiopathology</topic><topic>Biological and medical sciences</topic><topic>Blood Pressure - drug effects</topic><topic>Cardiovascular system</topic><topic>Coronary Circulation - drug effects</topic><topic>Coronary Vessels - drug effects</topic><topic>Coronary Vessels - pathology</topic><topic>Coronary Vessels - physiopathology</topic><topic>Dipyridamole - pharmacology</topic><topic>Female</topic><topic>Heart Diseases - drug therapy</topic><topic>Heart Diseases - physiopathology</topic><topic>Heart Ventricles - drug effects</topic><topic>Heart Ventricles - pathology</topic><topic>Hemodynamics - drug effects</topic><topic>Humans</topic><topic>Hypertension - drug therapy</topic><topic>Hypertension - physiopathology</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Myocardium - pathology</topic><topic>Perindopril - therapeutic use</topic><topic>Pharmacology. Drug treatments</topic><topic>Prospective Studies</topic><topic>Treatment Outcome</topic><topic>Vascular Resistance - drug effects</topic><topic>Vasodilator Agents - pharmacology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Schwartzkopff, Bodo</creatorcontrib><creatorcontrib>Brehm, Michael</creatorcontrib><creatorcontrib>Mundhenke, Markus</creatorcontrib><creatorcontrib>Strauer, Bodo E</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>MEDLINE - Academic</collection><jtitle>Hypertension (Dallas, Tex. 1979)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Schwartzkopff, Bodo</au><au>Brehm, Michael</au><au>Mundhenke, Markus</au><au>Strauer, Bodo E</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Repair of Coronary Arterioles After Treatment With Perindopril in Hypertensive Heart Disease</atitle><jtitle>Hypertension (Dallas, Tex. 1979)</jtitle><addtitle>Hypertension</addtitle><date>2000-08</date><risdate>2000</risdate><volume>36</volume><issue>2</issue><spage>220</spage><epage>225</epage><pages>220-225</pages><issn>0194-911X</issn><eissn>1524-4563</eissn><coden>HPRTDN</coden><abstract>In hypertensive heart disease, no data are available on the repair of coronary resistance vessels in patients after long-term ACE inhibitor treatment. Fourteen patients with essential hypertension were studied with coronary flow reserve and with transvenous endomyocardial biopsy before and after 12 months of antihypertensive treatment with perindopril (4 to 8 mg/d, mean 5.9±2.3 mg/d). Left ventricular muscle mass index decreased by 11% (from 145±41 to 128±36 g/m, P =0.04). Maximal coronary blood flow was increased by 54% (from 170±46 to 263±142 mL · min · 100 g, P =0.001), and minimal coronary vascular resistance was diminished by 33% (from 0.67±0.21 to 0.45±0.19 mm Hg · min · 100 g · mL, P =0.001); consequently, coronary reserve increased by 67% from 2.1±0.6 to 3.5±1.9 (P =0.001). Structural analysis revealed regression of periarteriolar collagen area by 54% (from 558±270 to 260±173 μm, P =0.04) and of total interstitial collagen volume density by 22% (from 5.5±3.8 Vv% to 4.3±3.2 Vv%, P =0.04), whereas arteriolar wall area was slightly but not significantly reduced. Long-term therapy with the ACE inhibitor perindopril induces structural repair of coronary arterioles that is mainly characterized by the regression of periarteriolar fibrosis and associated with a marked improvement in coronary reserve. These findings indicate the beneficial reparative effects of ACE inhibition on coronary microcirculation in hypertensive heart disease.</abstract><cop>Philadelphia, PA</cop><cop>Hagerstown, MD</cop><pub>American Heart Association, Inc</pub><pmid>10948081</pmid><doi>10.1161/01.HYP.36.2.220</doi><tpages>6</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0194-911X
ispartof Hypertension (Dallas, Tex. 1979), 2000-08, Vol.36 (2), p.220-225
issn 0194-911X
1524-4563
language eng
recordid cdi_proquest_miscellaneous_71761000
source EZB Electronic Journals Library
subjects Angiotensin-Converting Enzyme Inhibitors - therapeutic use
Antihypertensive agents
Arterioles - drug effects
Arterioles - pathology
Arterioles - physiopathology
Biological and medical sciences
Blood Pressure - drug effects
Cardiovascular system
Coronary Circulation - drug effects
Coronary Vessels - drug effects
Coronary Vessels - pathology
Coronary Vessels - physiopathology
Dipyridamole - pharmacology
Female
Heart Diseases - drug therapy
Heart Diseases - physiopathology
Heart Ventricles - drug effects
Heart Ventricles - pathology
Hemodynamics - drug effects
Humans
Hypertension - drug therapy
Hypertension - physiopathology
Male
Medical sciences
Middle Aged
Myocardium - pathology
Perindopril - therapeutic use
Pharmacology. Drug treatments
Prospective Studies
Treatment Outcome
Vascular Resistance - drug effects
Vasodilator Agents - pharmacology
title Repair of Coronary Arterioles After Treatment With Perindopril in Hypertensive Heart Disease
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T20%3A59%3A16IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Repair%20of%20Coronary%20Arterioles%20After%20Treatment%20With%20Perindopril%20in%20Hypertensive%20Heart%20Disease&rft.jtitle=Hypertension%20(Dallas,%20Tex.%201979)&rft.au=Schwartzkopff,%20Bodo&rft.date=2000-08&rft.volume=36&rft.issue=2&rft.spage=220&rft.epage=225&rft.pages=220-225&rft.issn=0194-911X&rft.eissn=1524-4563&rft.coden=HPRTDN&rft_id=info:doi/10.1161/01.HYP.36.2.220&rft_dat=%3Cproquest_cross%3E58594090%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c4762-79d74a9b8735d0ffaab78562b7ea2ba2960c144957861a59417514df15f73a1a3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=205281784&rft_id=info:pmid/10948081&rfr_iscdi=true